Ielasi, L.; Fulco, E.; Reggidori, N.; Domenicali, M.; Foschi, F.G.
Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications. Gastroenterol. Insights 2024, 15, 599-613.
https://doi.org/10.3390/gastroent15030044
AMA Style
Ielasi L, Fulco E, Reggidori N, Domenicali M, Foschi FG.
Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications. Gastroenterology Insights. 2024; 15(3):599-613.
https://doi.org/10.3390/gastroent15030044
Chicago/Turabian Style
Ielasi, Luca, Enrico Fulco, Nicola Reggidori, Marco Domenicali, and Francesco Giuseppe Foschi.
2024. "Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications" Gastroenterology Insights 15, no. 3: 599-613.
https://doi.org/10.3390/gastroent15030044
APA Style
Ielasi, L., Fulco, E., Reggidori, N., Domenicali, M., & Foschi, F. G.
(2024). Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications. Gastroenterology Insights, 15(3), 599-613.
https://doi.org/10.3390/gastroent15030044